Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article (Q36755742)
Jump to navigation
Jump to search
scientific article published on 22 October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article |
scientific article published on 22 October 2010 |
Statements
1 reference
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article (English)
1 reference
Howard A Riina
1 reference
Philip Stieg
1 reference
Jared Knopman
1 reference
Apostolos J Tsiouris
1 reference
John A Boockvar
1 reference
Christoph P Hofstetter
1 reference
Ilhami Kovanlikaya
1 reference
Sherese Fralin
1 reference
Kartik Kesavabhotla
1 reference
Stephen M Seedial
1 reference
Susan C Pannullo
1 reference
Theodore H Schwartz
1 reference
Robert D Zimmerman
1 reference
Ronald J Scheff
1 reference
Paul Christos
1 reference
Shankar Vallabhajosula
1 reference
22 October 2010
1 reference
1 reference
624-632
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference